Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Liver Cirrhosis 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Hemangiosarcoma 1 Glioma 1 Disease 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 16 Blood Specimen Collection 8 Temozolomide 5 Magnetic Resonance Imaging 5 Bevacizumab 4 Yoga 3 Radiotherapy, Intensity-Modulated 3 Biopsy 3 Transcranial Magnetic Stimulation 2 Surveys and Questionnaires 2 Restraint, Physical 2 Radiosurgery 2 Radiation 2 Psychosocial Intervention 2 Proton Therapy 2 Physical Therapy Modalities 2 Palliative Care 2 Mind-Body Therapies 2 Mental Status and Dementia Tests 2 Heart Rate 2 Gadolinium DTPA 2 Exercise 2 Elasticity Imaging Techniques 2 Drug Therapy 2 Diffusion Tensor Imaging 2 Congresses as Topic 2 Aminolevulinic Acid 2 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2 vandetanib 1 poly ICLC 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioma × Urination × Clear all

NCT06575452 2025-12-03

EPIGLIO

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡